These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24475255)

  • 1. Salvage liver transplantation for recurrent hepatocellular carcinoma after liver resection: retrospective study of the Milan and Hangzhou criteria.
    Hu Z; Zhou J; Li Z; Xiang J; Qian Z; Wu J; Zhang M; Zheng S
    PLoS One; 2014; 9(1):e87222. PubMed ID: 24475255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio.
    Xia W; Ke Q; Guo H; Wang W; Zhang M; Shen Y; Wu J; Xu X; Yan S; Yu J; Zhang M; Zheng S
    BMC Cancer; 2017 Jan; 17(1):14. PubMed ID: 28056901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage liver transplantation is a reasonable option for selected patients who have recurrent hepatocellular carcinoma after liver resection.
    Hu Z; Zhou J; Xu X; Li Z; Zhou L; Wu J; Zhang M; Zheng S
    PLoS One; 2012; 7(5):e36587. PubMed ID: 22574187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage liver transplantation for patients with recurrent hepatocellular carcinoma after curative resection.
    Wu L; Hu A; Tam N; Zhang J; Lin M; Guo Z; He X
    PLoS One; 2012; 7(7):e41820. PubMed ID: 22848619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage liver transplantation for recurrent hepatocellular carcinoma within UCSF criteria after liver resection.
    Liu F; Wei Y; Wang W; Chen K; Yan L; Wen T; Zhao J; Xu M; Li B
    PLoS One; 2012; 7(11):e48932. PubMed ID: 23145027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Milan criteria, University of California, San Francisco, criteria, and model for end-stage liver disease score as predictors of salvage liver transplantation.
    Zhang HM; Jiang WT; Pan C; Deng YL; Zheng H; Shen ZY
    Transplant Proc; 2015 Mar; 47(2):438-44. PubMed ID: 25769587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany.
    Qu Z; Ling Q; Gwiasda J; Xu X; Schrem H; Beneke J; Kaltenborn A; Krauth C; Mix H; Klempnauer J; Emmanouilidis N
    Langenbecks Arch Surg; 2018 Aug; 403(5):643-654. PubMed ID: 30120543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time interval to recurrence as a predictor of overall survival in salvage liver transplantation for patients with hepatocellular carcinoma associated with hepatitis B virus.
    Hu Z; Zhou J; Li Z; Xiang J; Qian Z; Wu J; Zhang M; Zheng S
    Surgery; 2015 Feb; 157(2):239-48. PubMed ID: 25616940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage liver transplantation for recurrent hepatocellular carcinoma after liver resection: feasibility of the Milan criteria and operative risk.
    Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
    Transplant Proc; 2008 Dec; 40(10):3558-61. PubMed ID: 19100437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma.
    Yadav DK; Chen W; Bai X; Singh A; Li G; Ma T; Yu X; Xiao Z; Huang B; Liang T
    Ann Transplant; 2018 Aug; 23():524-545. PubMed ID: 30072683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Early Recurrence of Hepatocellular Carcinoma in Patients with Cirrhosis Who Had Received Deceased Donor Liver Transplantation: A Multicenter Study.
    Al-Ameri AAM; Wei X; Liu P; Lin L; Shao Z; Xie H; Zhou L; Zheng S; Xu X
    Ann Transplant; 2019 Aug; 24():489-498. PubMed ID: 31427563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
    Xu X; Lu D; Ling Q; Wei X; Wu J; Zhou L; Yan S; Wu L; Geng L; Ke Q; Gao F; Tu Z; Wang W; Zhang M; Shen Y; Xie H; Jiang W; Wang H; Zheng S
    Gut; 2016 Jun; 65(6):1035-41. PubMed ID: 25804634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of survival and tumor recurrence rates in patients undergoing liver transplantation for hepatitis B-related hepatocellular carcinoma using Milan, Shanghai Fudan and Hangzhou criteria.
    Gao T; Xia Q; Qiu DK; Feng YY; Chi JC; Wang SY; Xi ZF; Zhang JJ; Xu N; Chen SY; Qiu YL; Shen LW; Zhou TT; Dong XJ; Li QG; Li H
    J Dig Dis; 2013 Oct; 14(10):552-8. PubMed ID: 23782458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
    Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM
    Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of Liver Transplantation for Hepatocellular Carcinoma in Terms of Different Criteria: A Single Center Experience.
    Lyu SC; Wang J; Ren ZY; Cao D; He Q
    Curr Med Sci; 2022 Jun; 42(3):548-554. PubMed ID: 35391617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of selected criteria and preventive chemotherapy in tumor recurrence after liver transplantation.
    Wang MX; Chen D; Zhao YY; Yang B; Jiang JP; Zeng FJ; Wei L; Chen ZS
    Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):378-383. PubMed ID: 32622825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary results of salvage liver transplantation in the patients with unresectable recurrent hepatocellular carcinoma after initial liver resection.
    Liang BY; Huang ZY; Zhou SJ; Hou P; Wang SF; Jiang B; Chen XP
    Hepatogastroenterology; 2014 Oct; 61(135):2014-20. PubMed ID: 25713904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage liver transplantation in the treatment of hepatocellular carcinoma: a meta-analysis.
    Li HY; Wei YG; Yan LN; Li B
    World J Gastroenterol; 2012 May; 18(19):2415-22. PubMed ID: 22654435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.
    Mazzaferro V; Llovet JM; Miceli R; Bhoori S; Schiavo M; Mariani L; Camerini T; Roayaie S; Schwartz ME; Grazi GL; Adam R; Neuhaus P; Salizzoni M; Bruix J; Forner A; De Carlis L; Cillo U; Burroughs AK; Troisi R; Rossi M; Gerunda GE; Lerut J; Belghiti J; Boin I; Gugenheim J; Rochling F; Van Hoek B; Majno P;
    Lancet Oncol; 2009 Jan; 10(1):35-43. PubMed ID: 19058754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.